methamphetamine and Parkinson Disease, Secondary

methamphetamine has been researched along with Parkinson Disease, Secondary in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (6.25)	18.7374
1990's	12 (37.50)	18.2507
2000's	5 (15.63)	29.6817
2010's	10 (31.25)	24.3611
2020's	3 (9.38)	2.80

Authors

Authors	Studies
Mavri, J; Pregeljc, D; Teodorescu-Perijoc, D; Umek, N; Vianello, R	1
Darke, S; Lappin, JM	1
Bing, G; Dang, DK; Hwang, Y; Jang, CG; Jeong, JH; Kim, HC; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ	1
Arab, A; Drazanova, E; Khairnar, A; Minsterova, A; Rektorova, I; Ruda-Kucerova, J; Starcuk, Z; Szabó, N	1
Lappin, JM; Sara, GE	1
Rusyniak, DE	1
Gupta, SP; Mishra, SK; Singh, MP; Singhal, NK; Tiwari, MN; Yadav, S	1
Carvey, PM; Kousik, SM; Napier, TC	1
Gedzior, JS; Matthew, BJ	1
Doi, D; Murayama, S; Nishimura, K; Onoe, H; Samata, B; Tahara, T; Takahashi, J	1
Fornai, F; Kastsiuchenka, O; Natale, G; Paparelli, A; Pasquali, L; Ruggieri, S	1
Daberkow, DP; Garris, PA; Howard, CD; Keefe, KA	1
Callaghan, RC; Cunningham, JK; Kish, SJ; Sykes, J	1
Carvey, PM; Graves, SM; Kousik, SM; Napier, TC; Zhao, C	1
Brown, VM; Cherry, SR; Khan, AH; Leahy, RM; Nichols, TE; Ossadtchi, A; Smith, DJ	1
Aceves, J; Anaya-Martínez, V; Bannon, MJ; Flores, G; Garcia-Villegas, R; Gonzalez-Barrios, JA; Jiménez, I; Lindahl, M; Martinez-Arguelles, DB; Martinez-Fong, D; Navarro-Quiroga, I; Segovia, J; Trudeau, LE	1
Abbey, R; Alexander, M; Brasic, J; Dannals, RF; Kumar, A; Kuwabara, H; McCann, UD; Palermo, M; Ricaurte, GA; Wong, DF; Ye, W	1
Hashiguchi, H; Ishida, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K	1
Di Monte, DA; Jakowec, MW; Langston, JW; Royland, JE	1
Hashitani, T; Hattori, S; Matsui, N; Nishino, H	1
Corsini, GU; Fornai, F; Maggio, R; Racagni, G; Riva, M; Vaglini, F	1
Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H	1
Hatori, K; Kondo, T; Mizuno, Y; Shimada, H; Sugita, Y	1
Dannals, RF; McCann, UD; Ricaurte, GA; Villemagne, V; Wong, DF; Yokoi, F	1
Hashiguchi, H; Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K	1
Green, S; Jakowec, MW; Petzinger, GM; Tolwani, RJ; Waggie, K	1
Brown, VM; Cherry, SR; Khan, AH; Lacan, G; Leahy, RM; Melega, WP; Ossadtchi, A; Smith, DJ; Yee, S	1
Johnson, SK; Medina, D; Wagner, GC	1
Matsui, Y; Mogami, H; Moriuchi, S; Shimizu, K; Tamura, K; Yamada, M	1
Dunnett, SB; Morris, BJ; Northrop, AJ; Sirinathsinghji, DJ	1
Hatanaka, H; Ikeda, T; Matsui, Y; Miyao, Y; Mogami, H; Okamoto, Y; Shimizu, K; Tsuda, N; Yamada, M	1
Beresford, IJ; Hall, MD; Heavens, RP; Richards, SJ; Sirinathsinghji, DJ	1

Reviews

6 review(s) available for methamphetamine and Parkinson Disease, Secondary

Article	Year
Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A review. Experimental neurology, 2021, Volume: 343 Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Methamphetamine; Parkinson Disease, Secondary; Risk Factors; Stroke	2021
Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease. Archives of pharmacal research, 2021, Volume: 44, Issue:7 Topics: Animals; Apoptosis; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Methamphetamine; Mice; Mitochondrial Dynamics; Oxidative Stress; Parkinson Disease, Secondary; Rats	2021
Psychostimulant use and the brain. Addiction (Abingdon, England), 2019, Volume: 114, Issue:11 Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke	2019
Neurologic manifestations of chronic methamphetamine abuse. The Psychiatric clinics of North America, 2013, Volume: 36, Issue:2 Topics: Amphetamine-Related Disorders; Cognition Disorders; Dental Caries; Dyskinesia, Drug-Induced; Humans; Methamphetamine; Paresthesia; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotyped Behavior	2013
Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease? Molecular neurobiology, 2014, Volume: 49, Issue:1 Topics: Animals; Humans; Methamphetamine; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Parkinsonian Disorders; Reactive Nitrogen Species; Rotenone	2014
Experimental models of Parkinson's disease: insights from many models. Laboratory animal science, 1999, Volume: 49, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reserpine	1999

Other Studies

26 other study(ies) available for methamphetamine and Parkinson Disease, Secondary

Article	Year
How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study. Neurotoxicity research, 2020, Volume: 37, Issue:3 Topics: Amphetamine; Animals; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drosophila melanogaster; Humans; Methamphetamine; Models, Neurological; Parkinson Disease, Secondary; Reserpine; Synapses; Vesicular Neurotransmitter Transport Proteins	2020
Diffusion Kurtosis Imaging Detects Microstructural Changes in a Methamphetamine-Induced Mouse Model of Parkinson's Disease. Neurotoxicity research, 2019, Volume: 36, Issue:4 Topics: Animals; Behavior, Animal; Brain; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Dopamine Agents; Male; Methamphetamine; Mice, Inbred C57BL; Parkinson Disease, Secondary	2019
Methamphetamine self-administration results in persistent dopaminergic pathology: implications for Parkinson's disease risk and reward-seeking. The European journal of neuroscience, 2014, Volume: 40, Issue:4 Topics: Animals; Brain; Dopaminergic Neurons; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reward; Risk Factors; Self Administration; Substantia Nigra; Ventral Tegmental Area	2014
Drug-induced parkinsonism following chronic methamphetamine use by a patient on haloperidol decanoate. International journal of psychiatry in medicine, 2015, Volume: 50, Issue:4 Topics: Adult; Amphetamine-Related Disorders; Diphenhydramine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Humans; Injections, Intramuscular; Male; Methamphetamine; Neural Pathways; Nucleus Accumbens; Parkinson Disease, Secondary; Patient Admission; Patient Readmission; Psychotic Disorders; Receptors, Dopamine D2; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substantia Nigra; Treatment Refusal	2015
Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1. Stem cell reports, 2016, Apr-12, Volume: 6, Issue:4 Topics: Aged; Animals; Cell Differentiation; Cells, Cultured; Corpus Striatum; Dopaminergic Neurons; Estradiol; Female; Gene Expression Profiling; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Integrin alpha5beta1; Male; Methamphetamine; Mice, Inbred C57BL; Microscopy, Confocal; Nerve Net; Neural Stem Cells; Oxidopamine; Parkinson Disease, Secondary; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Transplantation; Transplantation, Heterologous	2016
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut. Annals of the New York Academy of Sciences, 2008, Volume: 1139 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catecholamines; Dopamine Agents; Gastrointestinal Tract; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Parkinson Disease, Secondary; Random Allocation	2008
Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. Journal of neurochemistry, 2011, Volume: 118, Issue:4 Topics: Algorithms; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Electric Stimulation; Electrophysiological Phenomena; Extracellular Space; Kinetics; Male; Methamphetamine; Microelectrodes; Neurons; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Signal Transduction; Sympathectomy, Chemical; Sympatholytics	2011
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug and alcohol dependence, 2012, Jan-01, Volume: 120, Issue:1-3 Topics: Adult; Amphetamine-Related Disorders; Amphetamines; Appendicitis; Case-Control Studies; Cocaine-Related Disorders; Female; Hospitalization; Humans; Male; Methamphetamine; Middle Aged; Parkinson Disease, Secondary; Propensity Score; Retrospective Studies; Risk Factors	2012
Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Neuroreport, 2011, Dec-07, Volume: 22, Issue:17 Topics: Amphetamine-Related Disorders; Animals; Biomarkers; Cerebrovascular Disorders; Corpus Striatum; Dopamine; Fluorescein-5-isothiocyanate; Hypoxia, Brain; Male; Methamphetamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley	2011
Statistical analysis of multiplex brain gene expression images. Neurochemical research, 2002, Volume: 27, Issue:10 Topics: Analysis of Variance; Animals; Brain; Dopamine Agents; Gene Expression; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Models, Neurological; Parkinson Disease, Secondary; Reference Values	2002
Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats. Molecular therapy : the journal of the American Society of Gene Therapy, 2006, Volume: 14, Issue:6 Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Humans; Immunohistochemistry; Methamphetamine; Nanoparticles; Neurons; Neurotensin; Oxidopamine; Parkinson Disease, Secondary; Rats; Substantia Nigra; Time Factors; Transfection	2006
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse (New York, N.Y.), 2008, Volume: 62, Issue:2 Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Cocaine; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography	2008
Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Brain research, 1996, Jul-15, Volume: 727, Issue:1-2 Topics: Animals; Brain Tissue Transplantation; Caudate Nucleus; Corpus Striatum; Dizocilpine Maleate; Dopamine; Female; Fetal Tissue Transplantation; Levodopa; Mesencephalon; Methamphetamine; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Putamen; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase	1996
Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. Journal of neurochemistry, 1996, Volume: 67, Issue:6 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Dopamine Agents; Enzyme Inhibitors; Homovanillic Acid; Indazoles; Male; Methamphetamine; Mice; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Parkinson Disease, Secondary; Tyrosine 3-Monooxygenase	1996
Dynamic regulation of striatal dopaminergic grafts during locomotor activity. Brain research, 1996, Feb-26, Volume: 710, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Transplantation; Corpus Striatum; Dopamine; Extracellular Space; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Stereotyped Behavior; Substantia Nigra; Time Factors	1996
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:10 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Dopamine Uptake Inhibitors; Fibroblast Growth Factor 2; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neuroprotective Agents; Neurotoxins; Nicotine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase	1997
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts. Neuroscience research, 1998, Volume: 30, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase	1998
Talipexole protects dopaminergic neurons from methamphetamine toxicity in C57BL/6N mouse. Neuroscience letters, 1998, May-15, Volume: 247, Issue:2-3 Topics: Animals; Azepines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Enzyme Induction; Free Radical Scavengers; Gentisates; Hydroxybenzoates; Hydroxyl Radical; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Parkinson Disease, Secondary; Receptors, Dopamine D2; Salicylates; Salicylic Acid; Tyrosine 3-Monooxygenase	1998
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20 Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Propiophenones; Tomography, Emission-Computed	1998
Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease. Brain research, 1998, Oct-26, Volume: 809, Issue:1 Topics: Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase	1998
Multiplex three-dimensional brain gene expression mapping in a mouse model of Parkinson's disease. Genome research, 2002, Volume: 12, Issue:6 Topics: Animals; Brain Chemistry; Brain Mapping; Central Nervous System Stimulants; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Multigene Family; Parkinson Disease; Parkinson Disease, Secondary	2002
The effects of deprenyl on methamphetamine-induced dopamine depletions. Journal of neural transmission. General section, 1992, Volume: 89, Issue:1-2 Topics: Animals; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Parkinson Disease, Secondary; Selegiline; Serotonin	1992
Neural transplantation in mouse Parkinson's disease. Stereotactic and functional neurosurgery, 1990, Volume: 54-55 Topics: Animals; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Fetal Tissue Transplantation; Graft Survival; Immune Tolerance; Mesencephalon; Methamphetamine; Mice; Mice, Inbred Strains; Parkinson Disease, Secondary; Receptors, Dopamine; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase	1990
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts. Neuroscience, 1990, Volume: 37, Issue:3 Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Autoradiography; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Female; Fetal Tissue Transplantation; Immunohistochemistry; Injections; Methamphetamine; Neural Pathways; Parkinson Disease, Secondary; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra	1990
[Transplant-induced recovery from 6-OHDA lesions of the nigro-striatal dopamine neurons in mice]. No to shinkei = Brain and nerve, 1988, Volume: 40, Issue:7 Topics: Animals; Disease Models, Animal; Dopamine; Female; Hydroxydopamines; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Parkinson Disease, Secondary; Substantia Nigra; Transplantation, Homologous	1988
Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--I. Behavioural, neurochemical and histological characterization of the lesion. Neuroscience, 1988, Volume: 27, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Female; Functional Laterality; Methamphetamine; Parkinson Disease, Secondary; Posture; Pyridinium Compounds; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra	1988